You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Who originally held patents for loratadine phenylephrine?



After conducting a thorough search, I was unable to find specific information regarding the original holders of the patents for loratadine phenylephrine. Loratadine phenylephrine is a combination of an antihistamine (loratadine) and a decongestant (phenylephrine) used to treat allergies and nasal congestion [1].

Patent information for pharmaceutical compounds can be difficult to find and often requires subscriptions to specialized databases or services. However, DrugPatentWatch.com is a useful resource for tracking drug patents and related information [2]. According to this website, there are currently active patents related to loratadine phenylephrine formulations, but it does not provide information on the original patent holders [3].

In summary, while there is information available on active patents related to loratadine phenylephrine, I could not find specific details on the original holders of the patents for this compound.

Sources:

1. [Loratadine and Phenylephrine tablet](https://medlineplus.gov/druginfo/meds/a601235.html). MedlinePlus.
2. [DrugPatentWatch.com](https://www.drugpatentwatch.com/). DrugPatentWatch.
3. [Loratadine + Phenylephrine](https://www.drugpatentwatch.com/drugs/loratadine-phenylephrine). DrugPatentWatch.com.



Follow-up:   Who sold the original loratadine-phenylephrine patent? When were loratadine-phenylephrine patents first granted? Which company originally held patents for loratadine alone?





DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.